Tokunaga Atsushi, Saika Misako, Senba Emiko
Department of Anatomy and Neurobiology, Wakayama Medical College, 27 Kyuban-cho, Wakayama 640-8155, Japan.
Pain. 1998 Jun;76(3):349-355. doi: 10.1016/S0304-3959(98)00066-9.
The present study was designed to investigate which subtypes of 5-HT receptors are involved in 5-HT-induced hyperalgesia using behavioral assessment of hyperalgesia. 5-HT and various putative agonists for 5-HT receptor subtypes (5-HT(1A, 2, 3)) were intradermally injected into the rat ipsilateral hindpaw. Paw-withdrawal latency to radiant heat stimulation was examined every 15 min for 2 h. Injection of 5-HT (30 microg) and 5-HT2A receptor agonist (alpha-methyl 5-HT; 0.86 mg/kg) significantly reduced the paw-withdrawal latency. On the other hand, injection of 5-HT3 receptor agonists (2-methyl 5-HT; 0.86 mg/kg, m-CPG; 8 mg/kg) did not produce hyperalgesia. Furthermore, pretreatment with 5-HT2A receptor antagonist (ketanserin), but not with 5-HT3 receptor antagonist (tropisetron), attenuated the behavioral response after the injection of 5-HT. These findings strongly suggest that the 5-HT2A receptor subtype, but not the 5-HT3 subtype, is involved in 5-HT-induced hyperalgesia in acute injury and inflammation in the rat. In situ hybridization histochemistry revealed the presence of 5-HT2 receptor mRNA in a subpopulation of both large and small neurons in the rat dorsal root ganglia.
本研究旨在通过对痛觉过敏进行行为学评估,来探究5-羟色胺(5-HT)受体的哪些亚型参与了5-HT诱导的痛觉过敏。将5-HT及各种假定的5-HT受体亚型(5-HT(1A、2、3))激动剂皮内注射到大鼠同侧后爪。每隔15分钟检查一次对辐射热刺激的爪部撤回潜伏期,持续2小时。注射5-HT(30微克)和5-HT2A受体激动剂(α-甲基5-HT;0.86毫克/千克)显著缩短了爪部撤回潜伏期。另一方面,注射5-HT3受体激动剂(2-甲基5-HT;0.86毫克/千克,m-CPG;8毫克/千克)并未产生痛觉过敏。此外,用5-HT2A受体拮抗剂(酮色林)预处理,但不用5-HT3受体拮抗剂(托烷司琼)预处理,可减弱注射5-HT后的行为反应。这些发现有力地表明,在大鼠急性损伤和炎症中,5-HT诱导的痛觉过敏涉及5-HT2A受体亚型,而非5-HT3亚型。原位杂交组织化学显示,在大鼠背根神经节的大、小神经元亚群中均存在5-HT2受体mRNA。